Prof. Zaza Iakobishvili is a cardiologist and Associate Professor at Ben-Gurion University of the Negev, and Director of Community Cardiology for Clalit Health Services' Tel Aviv-Jaffa District. A pioneer of cardio-oncology in Israel, he founded the cardio-oncology clinic at Rabin Medical Center in 2013 and chairs the Israel Heart Society's Working Group on Cardio-Oncology. His research covers real-world outcomes in diabetes, hyperlipidemia, hypertension and heart failure. He advises the Ministry of Health on cardiovascular disease prevention

Prof. Zaza Iakobishvili, MD, PhD, FESC, FHFA Director, Community Cardiology, Clalit Health Services, Tel Aviv-Jaffa District | Ben-Gurion University of the Negev Prof. Zaza Iakobishvili is a cardiologist and Associate Professor of Cardiovascular Medicine at the Faculty of Health Sciences, Ben-Gurion University of the Negev. He directs the Department of Community Cardiology for Clalit Health Services' Tel Aviv-Jaffa District and the Heart Institute at Holon Medical Center. He is also a senior cardiologist and researcher at Samson Assuta Ashdod University Hospital and a senior researcher at Clalit's Clinical Outcomes Research Laboratory. A pioneer of cardio-oncology in Israel, he founded the cardio-oncology clinic at Rabin Medical Center's Davidoff Cancer Center in 2013. He founded and chairs the Israel Heart Society's Working Group on Cardio-Oncology, and previously chaired the Israeli Ministry of Health's multidisciplinary committee on cardio-oncology. He is a member of the ESC Heart Failure Association's Cardio-Oncology Study Group and has lectured on the subject at international meetings in Europe, the United States and elsewhere. His work in cardiometabolic medicine focuses on diabetes, hyperlipidemia, hypertension and heart failure. He is a member of the ESC Heart Failure Association Study Group on Diabetes and Hypertension. His real-world outcomes research includes studies of GLP-1 receptor agonists in diabetic patients with heart failure and the impact of PCSK9 inhibitor antibodies on cancer incidence. He trained at Tbilisi State Medical Institute and Rabin Medical Center, where he previously directed Emergency Cardiology Services. He advises the Ministry of Health on cardiovascular disease prevention. He has an h-index of 32 and more than 7,400 citations (Web of Science).